Anzeige
Mehr »
Freitag, 25.07.2025 - Börsentäglich über 12.000 News
Richtig investiert verwandelt der Goldpreis jeden Euro in glänzendes Vermögen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2ATTU | ISIN: HK0000311099 | Ticker-Symbol: 640
Tradegate
25.07.25 | 19:04
0,620 Euro
+1,64 % +0,010
Branche
Pharma
Aktienmarkt
ASIEN
1-Jahres-Chart
CHINA RESOURCES PHARMACEUTICAL GROUP LTD Chart 1 Jahr
5-Tage-Chart
CHINA RESOURCES PHARMACEUTICAL GROUP LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,5900,62022:42
0,5900,62021:46

Aktuelle News zur CHINA RESOURCES PHARMACEUTICAL Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
18.07.CHINARES PHARMA Plans to Establish Joint Venture Innovation Investment Fund1
17.07.CHINARES PHARMA (03320): VOLUNTARY ANNOUNCEMENT FORMATION OF THE FUND1
18.06.CHINARES PHARMA (03320): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS1
18.06.CHINARES PHARMA (03320): APPOINTMENT OF NON-EXECUTIVE DIRECTOR1
17.06.CHINARES PHARMA (03320): INSIDE INFORMATION COMPLETION OF THE PUBLIC ISSUANCE OF THE THIRD TRANCHE OF 2025 CORPORATE BONDS IN THE PRC2
09.06.CHINARES PHARMA (03320): DIVIDEND CURRENCY ELECTION FORM FOR THE FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 20241
28.05.Dividendenbekanntmachungen (28.05.2025)12.753 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  ABO ENERGY GMBH & CO KGAA  DE0005760029 - 0,65 EUR  AIA GROUP LTD  HK0000069689  1,3098 HKD  0,1474 EUR  ALLIANZ SE ADR  US0188201000  1...
► Artikel lesen
23.05.CHINARES PHARMA (03320): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS1
CHINA RESOURCES PHARMACEUTICAL Aktie jetzt für 0€ handeln
23.05.CHINARES PHARMA (03320): POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 23 MAY 2025 AND CHANGE OF INDEPENDENT NON-EXECUTIVE DIRECTORS AND COMPOSITION ...2
14.05.CHINARES PHARMA (03320): CONTINUING CONNECTED TRANSACTIONS COOPERATION AGREEMENT IN RELATION TO NEW ENERGY PROJECTS-
28.04.CHINARES PHARMA (03320): ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF CR SANJIU FOR THE THREE MONTHS ENDED 31 MARCH 20251
28.04.CHINARES PHARMA (03320): ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF KPC FOR THE THREE MONTHS ENDED 31 MARCH 20251
28.04.CHINARES PHARMA (03320): ANNOUNCEMENT UNAUDITED FINANCIAL RESULTS OF TASLY PHARMACEUTICALS FOR THE THREE MONTHS ENDED 31 MARCH 2025-
28.04.CHINARES PHARMA (03320): 2024 SUSTAINABILITY REPORT1
28.04.CHINARES PHARMA (03320): NOTIFICATION OF PUBLICATION OF CORPORATE COMMUNICATIONS ON THE COMPANY'S WEBSITE1
28.04.CHINARES PHARMA (03320): LETTER TO NEW SHAREHOLDERS - ELECTION OF MEANS OF RECEIPT OF CORPORATE COMMUNICATIONS2
28.04.CHINARES PHARMA (03320): LETTER TO THOSE SHAREHOLDERS WHO HAVE ELECTED TO RECEIVE THE CORPORATE COMMUNICATIONS THROUGH THE COMPANY'S WEBSITE1
28.04.CHINARES PHARMA (03320): LETTER TO THOSE SHAREHOLDERS WHO HAVE ELECTED TO RECEIVE THE PRINTED FORM OF CORPORATE COMMUNICATIONS1
28.04.CHINARES PHARMA (03320): PROXY FORM1
28.04.CHINARES PHARMA (03320): NOTICE OF ANNUAL GENERAL MEETING1
Weiter >>
40 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1